BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 7522163)

  • 1. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
    Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
    Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
    Wettstein PJ; van Bleek GM; Nathenson SG
    J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
    Haurum JS; Tan L; Arsequell G; Frodsham P; Lellouch AC; Moss PA; Dwek RA; McMichael AJ; Elliott T
    Eur J Immunol; 1995 Dec; 25(12):3270-6. PubMed ID: 8566011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A; Schirmbeck R; Reimann J
    Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.
    Heath WR; Vitiello A; Sherman LA
    J Immunol; 1989 Sep; 143(5):1441-6. PubMed ID: 2474598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH
    J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.